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Natural products are a constant source of potentially active 
compounds for the treatment of various disorders. There are several 
hundreds of drugs being designed and developed based on plant 
secondary metabolites all over the world. It should also be 
highlighted that plants (or their parts) are used as infusions, 
tincture, or in the form of crude extracts for treatment of various 
human disorders (St. John wort utilized in the treatment of mild to 
moderate depressions; Devil’s claw against inflammations, etc). The 
World Health Organization estimates that 4 billion people (i.e. 80% 
of the World’s population) use herbal medicines in some aspects of 
primary healthcare and there is a growing tendency to “Go Natural”, 
which altogether comprise an annual market of several billion US 
dollars. This has opened up a huge and potential window for 
research and challenges a number of scientists in exploring the 
(still) hidden part of nature in searching for new drug leads from 
plants. It is to be noted that currently an about half of the plant 
species have been described as only 10% of them have been 
scientifically investigated. Current research in drug discovery from 
medicinal plants involves a multifaceted approach combining 
botanical, phytochemical, biological, and molecular techniques. The 
early drugs discovered from medicinal plants such as such as 
morphine, cocaine, codeine, digitoxin, and quinine, are still in use. It 
is to be noted that of all available anticancer drugs, 40% are natural 
products per se and/or natural product-derived with another 8% 
considered being natural product mimics. Several natural product 
drugs of plant origin have either recently been introduced into the 
market or are currently involved in late-phase clinical trials. 
The purpose of this special issue is to discuss the current advancements 
in the development of drug leads from plants for prevention of socio-
significant diseases like snakebite, diabetes, cancer, inflammation, 
cardiovascular diseases, etc., proven to be very important by several 
(epidemiological) studies, their medicinal chemistry, and mechanism of 
action. Further, it highlights the therapeutical potential of various plants 
and/or their metabolites in treatment of various disorders. It also 
focuses to cover some modern and emerging techniques for finding 
therapeutic leads to combat disorders.  
I expect this special issue containing of 45 manuscripts to be of great 
interest for researchers from the medical and technological fields, 
opening new directions for the design and development of 
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